Skip to main content

Corporate insider profile

Robert C. Goeltz II Insider Trades

Robert C. Goeltz II has reported no open-market purchases on SEC Form 4 and is a net seller of $198,966 across 1 company. The most recent open-market transaction was reported on May 11, 2026. Source: SEC Form 4 filings.

Latest reported as Chief Financial Officer of Arcus Biosciences, Inc. (RCUS).

SEC-reported filing activity is provided for research purposes and is not investment advice.

Purchase filings
0
Reported companies
1
Net open-market value
-$198,965.69
Latest transaction
May 11, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 11, 2026Arcus Biosciences, Inc. (RCUS)Chief Financial OfficerSale7,763$25.63$198,966

Common questions

Robert C. Goeltz II insider trading FAQ

Is Robert C. Goeltz II buying or selling stock?
Across all SEC Form 4 open-market filings on record, Robert C. Goeltz II is a net seller of $198,966, with no open-market purchases reported. The latest transaction was reported on May 11, 2026.
Which companies does Robert C. Goeltz II report insider trades for?
Robert C. Goeltz II has reported open-market trades in Arcus Biosciences, Inc. (RCUS). The latest SEC-reported relationship is Chief Financial Officer of Arcus Biosciences, Inc. (RCUS).
Where does Robert C. Goeltz II's insider trading data come from?
Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1653881, and refreshes this page daily.